Last reviewed · How we verify
NCT03887247
Reducing Concurrent Opioid-Benzodiazepine Prescriptions
NA trial testing E-mail Alert in Adverse Drug Effect of Opioids in 2,234 participants. Status unknown.
29 July 2021
Quick facts
| Lead sponsor | Walter Reed National Military Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 2,234 |
| Start date | 6 June 2019 |
| Primary completion | 29 July 2021 |
| Estimated completion | 1 June 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- E-mail Alert
Conditions studied
- Adverse Drug Effect of Opioids — all drugs for Adverse Drug Effect of Opioids →
- Adverse Drug Effect of Benzodiazepines — all drugs for Adverse Drug Effect of Benzodiazepines →
Sponsor
Walter Reed National Military Medical Center
Who can join
18 and older, any sex, with Adverse Drug Effect of Opioids or Adverse Drug Effect of Benzodiazepines. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this effort is to use informative e-mails to improve the process of prescribing of opioids and benzodiazepines within the National Capital Region/Military Health System (NCR/MHS), with the aim of decreasing concurrent opioid and benzodiazepine prescribing.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of Pharmacist Email Alerts on Concurrent Prescribing of Opioids and Benzodiazepines by Prescribers and Primary Care Managers: A Randomized Clinical Trial.
Sacarny A, Safran E, Steffel M, Dunham JR, et al · · 2022 · cited 4× · PMID 36218952 · DOI 10.1001/jamahealthforum.2022.3378
Verify or expand the search:
- PubMed search for NCT03887247
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Walter Reed National Military Medical Center trials
Trials by the same sponsor.
- NCT07151417 — Use of Corticosteroid in Intraopertive Injections in Total Knee Replacement Surgery. · Phase 2, PHASE3 · not yet recruiting
- NCT06636136 — Transtibial Osseointegration · NA · recruiting
- NCT06808347 — Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Pos · Phase 4 · not yet recruiting
- NCT06731348 — Patient Satisfaction With Opioid Restriction After Urogynecologic Surgery · Phase 4 · enrolling by invitation
- NCT06729151 — Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patient · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03887247 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Walter Reed National Military Medical Center
- Last refreshed: 19 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03887247.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing